Strategic Representation Portfolio
We selectively represent high-value medical brands and actively drive their commercial success in Saudi Arabia.

Strategic Representation Portfolio

Selective mandates built to accelerate brand adoption, repeat orders, and sustainable commercial growth in Saudi Arabia.

Authorized DistributorAuthorized Manufacturer

INI Medical Devices

Medical aesthetic injection solutions. ENE PRO distributes selected INI product lines through professional medical channels and supports clinics through structured onboarding and technical support.

INI Medical Devices
Explore ProductsVisit Manufacturer
Active & In-Progress Mandates

Proven Market Execution Case

Due to exclusive agreements, some partner details remain confidential.

Proven Market Execution Highlight

A representative execution snapshot from a confidential injectables mandate.

SFDA Registration PathTypical 9–12 months
Initial Market ActivationMulti-city clinic onboarding
Reorder SignalsRepeat purchasing behavior
CH

Leading Swiss Aesthetic Injectables Brand (Confidential Mandate)

Switzerland
CategoryAesthetic Injectables
Regulatory ClassClass III
Mandate StatusConfidential Mandate
DE

Leading European Class III Device Brand (Active Mandate)

Germany
CategoryEnergy-Based Devices
Regulatory ClassClass III
Mandate StatusActive Mandate
UK

Global Medical Aesthetics Firm (Selective Engagement)

United Kingdom
CategoryAdvanced Skincare
Regulatory ClassClass II
Mandate StatusConfidential Review
Representation Protocol

Governance & Representation Model

We do more than manage mandates. We build brands and generate measurable commercial success through disciplined in-market execution—while maintaining regulatory accountability and clinical integrity.

In-market commercial execution and key account management
Physician engagement, training, and clinic-level activation
Regulatory governance and SFDA lifecycle accountability
Post-market vigilance and disciplined license maintenance
Engagement Framework

Mandate Selection Criteria

We engage selectively with manufacturers positioned for sustainable commercial growth in Saudi Arabia and aligned with enterprise-grade execution standards:

International regulatory compliance (CE / FDA alignment)
Clinical validation and documented efficacy standards
Strong commercial potential in the Saudi aesthetic market
Long-term market commitment (non-opportunistic entry)
Alignment with controlled, value-based distribution

Examine our active footprint across the Kingdom

Market Presence
Limited Mandate Model

Market Access Strategy Inquiry

We operate a carefully limited mandate model per clinical category to protect brand standards and execution quality for our partners.

Start a confidential discussion to assess commercial fit, market readiness, and execution capacity for Saudi Arabia.

Discuss Representation OpportunitiesSchedule Executive Call